ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.00
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,524.98
0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) News

NUVB Panacea Acquisition Corp

2.75
0.13 (4.96%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Panacea Acquisition Corp NUVB NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.13 4.96% 2.75 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.63 2.61 2.76 2.68 2.62
more quote information »

Recent News

Date Time Source Heading
4/24/202409:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
4/10/202415:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
3/28/202407:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
3/25/202406:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
3/14/202415:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
3/04/202416:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/04/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202415:48EDGAR2Form 8-K - Current report
2/29/202415:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
1/10/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/10/202415:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/08/202415:58DJNNuvation Bio Gets New Drug Application Clearance From FDA..
1/08/202415:17EDGAR2Form 8-K - Current report
1/08/202415:10BWNuvation Bio Announces Appointment of Dr. Robert Mashal to..
1/08/202415:05BWNuvation Bio Announces FDA Clearance of Investigational New..
12/14/202315:02EDGAR2Form 8-K - Current report
11/27/202315:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/27/202315:01EDGAR2Form 8-K - Current report
11/13/202315:11EDGAR2Form 8-K - Current report
11/13/202315:05BWNuvation Bio Announces Departure of Chief Financial Officer
11/02/202315:23EDGAR2Form 8-K - Current report
11/02/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:10BWNuvation Bio Reports Third Quarter 2023 Financial Results..
8/03/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:17EDGAR2Form 8-K - Current report
8/03/202315:10BWNuvation Bio Reports Second Quarter 2023 Financial Results..
6/01/202315:05BWNuvation Bio Announces Formation of Oncology-Focused..
5/04/202315:05BWNuvation Bio Reports First Quarter 2023 Financial Results..

Your Recent History

NYSE
NUVB
Panacea Acquisition
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved